Boosters for Immunocompromised and Patients at High Risk

Slides | Recording

Educational Objectives: 

1. Understand differences in eligibility and efficacy between the third dose and booster.

2. List recommendations on communicating third dose and booster information with both clinical staff and patients.

3. Considerations for promoting third dose and booster shots to high risk patients.

Panelists included:

  • Mary Blankson, DNP, APRN, FNP-C, FAAN, Chief Nursing Officer, CHC, Inc.
  • Natalie Bycenski, Senior Nurse Manager, Community Health Center Inc.
  • Leslie Gianelli, Vice President of Communications, Community Health Center Inc.
  • Marie Yardis, Access to Care Director, Community Health Center Inc.
  • Amanda Schiessl, MPP, Deputy Operations Officer/Co-Principal Investigator, Community Health Center, Inc./Weitzman Institute
  • Stephen Scholand, MD, Infectious Disease Specialist, MidState Medical Center

Additional Resources: 

Leslie Gianelli’s slides on communicating information about the vaccine to patients